Sectors
IBIO
iBio, Inc.
1.27
2 x 0.99
2 x 1.62
bid
ask
-
0.09
6.62%
2 @ 07:53 PM
1.32 +0.05 (3.94%)
| Ytd | -34.20% | |
| 1y | 54.88% |
1.25
day range
1.37
0.77
52 week range
3.82
| Open | 1.36 | Prev Close | 1.36 | Low | 1.25 | High | 1.37 | Mkt Cap | 63.09M |
| Vol | 875.83K | Avg Vol | 857.03K | EPS | -0.32 | P/E | N/A | Forward P/E | -1.44 |
| Beta | 1.30 | Short Ratio | 1.92 | Inst. Own | 31.49% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 09-22 | 50-d Avg | 1.49 | 200-d Avg | 1.84 | 1yr Est | 3.60 |
| Income Statement | |||
| Operating Expenses | 11.38M | ||
| Research and Development Expense | 8.56M | ||
| Selling, General and Administrative Expense | 2.82M | ||
| Operating Income | -11.38M | ||
| Interest Expense | -46.00K | ||
| Net Income | -10.60M | ||
| Net Income Common Stock | -10.60M | ||
| Net Income Common Stock (USD) | -10.60M | ||
| Consolidated Income | -10.60M | ||
| Earnings per Basic Share | -0.07 | ||
| Earnings per Basic Share (USD) | -0.07 | ||
| Earnings per Diluted Share | -0.07 | ||
| Earning Before Interest & Taxes (EBIT) | -10.65M | ||
| Earning Before Interest & Taxes (USD) | -10.65M | ||
| Weighted Average Shares | 104.06M | ||
| Weighted Average Shares Diluted | 104.06M | ||
| Balance Sheet | |||
| Cash and Equivalents | 56.62M | ||
| Cash and Equivalents (USD) | 56.62M | ||
| Investments | 32.75M | ||
| Investments Current | 32.75M | ||
| Current Assets | 92.22M | ||
| Property, Plant & Equipment Net | 4.75M | ||
| Total Assets | 99.11M | ||
| Debt Current | 546.00K | ||
| Total Debt | 2.20M | ||
| Current Liabilities | 11.75M | ||
| Debt Non-Current | 1.65M | ||
| Total Liabilities | 13.40M | ||
| Accumulated Retained Earnings (Deficit) | -365.27M | ||
| Accumulated Other Comprehensive Income | -45.00K | ||
| Shareholders Equity | 85.71M | ||
| Shareholders Equity (USD) | 85.71M | ||
| Assets Non-Current | 6.89M | ||
| Total Debt (USD) | 2.20M | ||
| Deferred Revenue | 1.15M | ||
| Goodwill and Intangible Assets | 1.83M | ||
| Liabilities Non-Current | 1.65M | ||
| Trade and Non-Trade Payables | 4.42M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 250.00K | ||
| Net Cash Flow from Financing | 19.40M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 8.76M | ||
| Capital Expenditure | -19.00K | ||
| Issuance (Purchase) of Equity Shares | 25.50M | ||
| Net Cash Flow from Investing | -4.41M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -4.39M | ||
| Net Cash Flow from Operations | -6.23M | ||
| Share Based Compensation | 420.00K | ||